Soleno Therapeutics, Inc. (NASDAQ:SLNO) Receives $115.92 Consensus Price Target from Analysts
Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the fourteen ratings firms that are presently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating, twelve have assigned a buy rating and one has issued a strong buy rating […]
20 Oct 01:30 · The Cerbat Gem